These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 27827301)
41. MTH1 as a target to alleviate T cell driven diseases by selective suppression of activated T cells. Karsten S; Fiskesund R; Zhang XM; Marttila P; Sanjiv K; Pham T; Rasti A; Bräutigam L; Almlöf I; Marcusson-Ståhl M; Sandman C; Platzack B; Harris RA; Kalderén C; Cederbrant K; Helleday T; Warpman Berglund U Cell Death Differ; 2022 Jan; 29(1):246-261. PubMed ID: 34453118 [TBL] [Abstract][Full Text] [Related]
42. Mechanisms of MTH1 inhibition-induced DNA strand breaks: The slippery slope from the oxidized nucleotide pool to genotoxic damage. Rai P; Sobol RW DNA Repair (Amst); 2019 May; 77():18-26. PubMed ID: 30852368 [TBL] [Abstract][Full Text] [Related]
43. MTH1, an 8-oxo-2'-deoxyguanosine triphosphatase, and MYH, a DNA glycosylase, cooperate to inhibit mutations induced by chronic exposure to oxidative stress of ionising radiation. Shakeri Manesh S; Sangsuwan T; Pour Khavari A; Fotouhi A; Emami SN; Haghdoost S Mutagenesis; 2017 May; 32(3):389-396. PubMed ID: 28340109 [TBL] [Abstract][Full Text] [Related]
44. OGG1 co-inhibition antagonizes the tumor-inhibitory effects of targeting MTH1. Zhang L; Misiara L; Samaranayake GJ; Sharma N; Nguyen DM; Tahara YK; Kool ET; Rai P Redox Biol; 2021 Apr; 40():101848. PubMed ID: 33450725 [TBL] [Abstract][Full Text] [Related]
45. MutT Homolog 1 (MTH1): The Silencing of a Target. Papeo G J Med Chem; 2016 Mar; 59(6):2343-5. PubMed ID: 26924380 [TBL] [Abstract][Full Text] [Related]
46. The impact of OGG1, MTH1 and MnSOD gene polymorphisms on 8-hydroxy-2'-deoxyguanosine and cellular superoxide dismutase activity in myocardial ischemia-reperfusion. Karahalil B; Kesimci E; Emerce E; Gumus T; Kanbak O Mol Biol Rep; 2011 Apr; 38(4):2427-35. PubMed ID: 21104149 [TBL] [Abstract][Full Text] [Related]
47. (S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1. Dai X; Guo G; Zou P; Cui R; Chen W; Chen X; Yin C; He W; Vinothkumar R; Yang F; Zhang X; Liang G J Exp Clin Cancer Res; 2017 Sep; 36(1):120. PubMed ID: 28882182 [TBL] [Abstract][Full Text] [Related]
48. OGG1, MYH and MTH1 gene variants identified in gastric cancer patients exhibiting both 8-hydroxy-2'-deoxyguanosine accumulation and low inflammatory cell infiltration in their gastric mucosa. Goto M; Shinmura K; Yamada H; Tsuneyoshi T; Sugimura H J Genet; 2008 Aug; 87(2):181-6. PubMed ID: 18776649 [No Abstract] [Full Text] [Related]
49. MTH1 Inhibitors for the Treatment of Psoriasis. Bivik Eding C; Köhler I; Verma D; Sjögren F; Bamberg C; Karsten S; Pham T; Scobie M; Helleday T; Warpman Berglund U; Enerbäck C J Invest Dermatol; 2021 Aug; 141(8):2037-2048.e4. PubMed ID: 33676948 [TBL] [Abstract][Full Text] [Related]
50. Hypoxic Signaling and the Cellular Redox Tumor Environment Determine Sensitivity to MTH1 Inhibition. Bräutigam L; Pudelko L; Jemth AS; Gad H; Narwal M; Gustafsson R; Karsten S; Carreras Puigvert J; Homan E; Berndt C; Berglund UW; Stenmark P; Helleday T Cancer Res; 2016 Apr; 76(8):2366-75. PubMed ID: 26862114 [TBL] [Abstract][Full Text] [Related]
51. Investigation of micronucleus induction in MTH1 knockdown cells exposed to UVA, UVB or UVC. Fotouhi A; Cornella N; Ramezani M; Wojcik A; Haghdoost S Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():161-5. PubMed ID: 26520386 [TBL] [Abstract][Full Text] [Related]
52. Crystal structure of human MTH1 and the 8-oxo-dGMP product complex. Svensson LM; Jemth AS; Desroses M; Loseva O; Helleday T; Högbom M; Stenmark P FEBS Lett; 2011 Aug; 585(16):2617-21. PubMed ID: 21787772 [TBL] [Abstract][Full Text] [Related]
53. Overexpressed c-Myc Sensitizes Cells to TH1579, a Mitotic Arrest and Oxidative DNA Damage Inducer. Henriksson S; Calderón-Montaño JM; Solvie D; Warpman Berglund U; Helleday T Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551206 [TBL] [Abstract][Full Text] [Related]
54. Synergistic therapy of chemotherapeutic drugs and MTH1 inhibitors using a pH-sensitive polymeric delivery system for oral squamous cell carcinoma. Li X; Li L; Huang Y; Liu B; Chi H; Shi L; Zhang W; Li G; Niu Y; Zhu X Biomater Sci; 2017 Sep; 5(10):2068-2078. PubMed ID: 28744533 [TBL] [Abstract][Full Text] [Related]
55. MTH1 Inhibitor TH287 Suppresses Gastric Cancer Development Through the Regulation of PI3K/AKT Signaling. Zhan D; Zhang X; Li J; Ding X; Cui Y; Jia J Cancer Biother Radiopharm; 2020 Apr; 35(3):223-232. PubMed ID: 32077746 [No Abstract] [Full Text] [Related]
56. PRDX1 and MTH1 cooperate to prevent ROS-mediated inhibition of telomerase. Ahmed W; Lingner J Genes Dev; 2018 May; 32(9-10):658-669. PubMed ID: 29773556 [TBL] [Abstract][Full Text] [Related]
57. Cellular 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate pyrophosphohydrolase activity of human and mouse MTH1 proteins does not depend on the proliferation rate. Bialkowski K; Kasprzak KS Free Radic Biol Med; 2004 Nov; 37(10):1534-41. PubMed ID: 15477005 [TBL] [Abstract][Full Text] [Related]
58. Development of MTH1-Binding Nucleotide Analogs Based on 7,8-Dihalogenated 7-Deaza-dG Derivatives. Shi H; Ishikawa R; Heh CH; Sasaki S; Taniguchi Y Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525366 [TBL] [Abstract][Full Text] [Related]
59. MutT Homolog1 has multifaceted role in glioma and is under the apparent orchestration by Hypoxia Inducible factor1 alpha. Bhavya B; Easwer HV; Vilanilam GC; Anand CR; Sreelakshmi K; Urulangodi M; Rajalakshmi P; Neena I; Padmakrishnan CJ; Menon GR; Krishnakumar K; Deepti AN; Gopala S Life Sci; 2021 Jan; 264():118673. PubMed ID: 33130078 [TBL] [Abstract][Full Text] [Related]